enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
9.34
+0.24 (2.64%)
At close: Jan 21, 2026, 4:00 PM EST
8.96
-0.38 (-4.07%)
After-hours: Jan 21, 2026, 7:30 PM EST
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $625.64 million as of January 21, 2026. Its market cap has increased by 73.84% in one year.
Market Cap
625.64M
Enterprise Value
463.70M
1-Year Change
73.84%
Ranking
Category
Stock Price
$9.34
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $625.64M, an increase of 301.28%. That is a compound annual growth rate of 41.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 609.56M | 0.78% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |